Cat. No. | Product name | CAS No. |
DC5150 |
Veliparib (ABT-888 hydrochloride)
Featured
Veliparib is a potent inhibitor of both PARP-1 and PARP-2 by [3H]NAD+ with Kis of 5.2 and 2.9 nmol/L, respectively. |
912445-05-7 |
DC7187 |
Volasertib(BI6727)
Featured
Volasertib(BI6727) is a highly potent PLK1 inhibitor with an IC50 of 0.87 nM; shows 6- and 65-fold greater selectivity against Plk2 and Plk3. |
755038-65-4 |
DC7530 |
Voreloxin
Featured
Voreloxin(SNS-595; AG 7352) is a small molecule and a naphthyridine analogue with antineoplastic activity; inhibitor of Topo II. |
175414-77-4 |
DC10750 |
Voruciclib
Featured
Voruciclib is a protein kinase inhibitor specific for the cyclin-dependent kinase 4 (CDK4) with potential antineoplastic activity. |
1000023-04-0 |
DC3106 |
VX-680 (MK-0457,Tozasertib)
Featured
VX-680 (MK-0457, Tozasertib) is a pan-Aurora inhibitor of Aurora A, Aurora B and Aurora C with Kiapp of 0.6 nM, 18 nM and 4.6 nM, respectively. |
639089-54-6 |
DC8068 |
WHI-P180(Janex 3)
Featured
WHI-P180(Janex 3) is a potent inhibitor of IgE-mediated mast cell responses to allergens in vitro and in vivo. Also inhibits cyclin-dependent kinase 2 (CDK2; IC50 = 1µM) by blocking the ATP site |
211555-08-7 |
DC7533 |
wiki4
Featured
WIKI4 is a novel Tankyrase inhibitor with IC50 of 15 nM for TNKS2, and leads to inhibition of Wnt/beta-catenin signaling. |
838818-26-1 |
DC1028 |
Y-27632 2HCL
Featured
Y-27632 2HCl is a selective ROCK1 (p160ROCK) inhibitor with Ki of 140 nM. |
129830-38-2 |
DC10375 |
YU238259
Featured
YU238259 is a novel inhibitor of homology-dependent DNA repair(HDR), but does not inhibit non-homologous end-joining (NHEJ), in cell-based GFP reporter assays. |
1943733-16-1 |
DC10167 |
ZINC00881524
ZINC00881524 is a ROCK inhibitor. |
557782-81-7 |
DC1084 |
ZM447439 (ZM-447439)
ZM-447439 is a selective and ATP-competitive inhibitor for Aurora A and Aurora B with IC50 of 110 nM and 130 nM, respectively. |
331771-20-1 |
DC11139 |
ZYTP1
ZYTP1 is a novel, oral PARP inhibitor that inhibits PARP1, PARP2, Tankyrase-1 and Tankyrase-2 with IC50 of 5.4, 0.7, 133.3 and 289.8 nM, respectively. |
1616891-07-6 |
DC11254 | iCDK9 | 1263369-28-3 |
DC11253 | Amt-87 | 1609019-52-4 |
DC9246 |
PJ34(free base)
Featured
PJ34 is a potent specific inhibitor of PARPl/2 with IC50 of 110 nM and 86 nM, respectively. |
344458-19-1 |
DC11075 | Amelparib | 1227156-72-0 |
DC5087 |
Mps1-IN-1
Mps1-IN-1 is a highly potent and selectibe Mpsl inhibitor with IC50 of 367 nM; >1000-fold selectivity relative to the 352 member kinase panel with the major exceptions of Alk and Ltk. |
1125593-20-5 |
DC11282 |
THZ2
Featured
THZ2 is a potent and selective CDK7 inhibitor with IC50 of 13.9 nM. |
1604810-84-5 |
DC8861 |
2'-Deoxythioguanosine
Featured
6-thio-dG is a nucleoside analog and telomerase substrate. |
789-61-7 |
DC8516 |
BMS-5
Featured
BMS-5 is a potent inhibitor of the LIM kinase. It has IC50 values of 7nM and 8 nM for LIMK1 and LIMK2 respectively. |
1338247-35-0 |
DC7866 |
NMS-P715
Featured
NMS-P715 is the first selective, ATP-competitive and orally bioavailable MPS1 small-molecule inhibitor(IC50=8 nM); selectively reduces cancer cell proliferation, leaving normal cells almost unaffected. |
1202055-32-0 |
DC7493 |
SB1317(TG-02)
Featured
SB1317(TG-02) is a novel small molecule potent CDK2/JAK2/FLT3 inhibitor with IC50s of 13/73/56 nM respectively. |
937270-47-8 |